Southern Cancer Center

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Follicular lymphoma2 trials
• Bladder cancer1 trial
• Childhood cancers1 trial
• Kidney cancer1 trial
• Liver and biliary tract cancer1 trial
• Lung cancer1 trial
• Pancreatic cancer1 trial

Phase

• Phase 33 trials
• Phase 22 trials

Status

• Completed4 trials
• Active, not recruiting1 trial

Lead sponsor

• Aadi Bioscience, Inc.1 trial
• Boehringer Ingelheim1 trial
• Epizyme, Inc.1 trial
• Pfizer1 trial
• Pharmacyclics LLC.1 trial

Running trials

• Active, not recruiting

  A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.

  NCT04224493· Phase 3· Epizyme, Inc.· Source

Closed trials

• Completed

  Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

  NCT05512377· Phase 2· Boehringer Ingelheim· Source

• Completed

  Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

  NCT05103358· Phase 2· Aadi Bioscience, Inc.· Source

• Completed

  Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma

  NCT02947347· Phase 3· Pharmacyclics LLC.· Source

• Completed

  A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)

  NCT02684006· Phase 3· Pfizer· Source